GRIN2B and neoplasm: More interestingly, the treatment of mice with the GluN2B antagonist ifenprodil (2.5 mg/kg body weight) prevented the growth of PanC-1 tumor xenografts and decreased the tumor size by almost half, indicating that ifenprodil is more effective in the inhibition of NMDAR in vivo (107).